Experienced in Large-Cell Immunoblastic Lymphoma

Dr. Tami L. Bach

Hematology
Penn Medicine
Penn Hematology/Oncology Woodbury Heights
1006 Mantua Pike, 
Woodbury Heights, NJ 
On Staff At
Accepting New Patients
Experienced in Large-Cell Immunoblastic Lymphoma
Penn Medicine
Penn Hematology/Oncology Woodbury Heights
1006 Mantua Pike, 
Woodbury Heights, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Tami Bach is a Hematologist in Woodbury Heights, New Jersey. Dr. Bach is rated as an Experienced provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Non-Hodgkin Lymphoma, and Urothelial Cancer. Dr. Bach is currently accepting new patients.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Jefferson Medical College
Residency
Thomas Jefferson University
Specialties
Hematology
Licenses
Internal Medicine in NJ
Board Certifications
Medical Oncology, 2007
Hematology, 2004
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Inspira Medical Center Vineland
Inspira Medical Center Mullica Hill
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Penn Hematology/Oncology Woodbury Heights
1006 Mantua Pike, Woodbury Heights, NJ 8097.
Call: 800-789-7366

Additional Areas of Focus

Dr. Bach has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pernicious Anemia
Thalassemia
Myelofibrosis
Protein C Deficiency
Protein S Deficiency
Hemolytic Anemia
Anemia
Langerhans Cell Histiocytosis
Hereditary Spherocytosis
Immune Thrombocytopenic Purpura (ITP)
Vitamin B12 Deficiency
Beta Thalassemia
Sickle Cell Disease
Blood Clots
Porphyria
Dyskeratosis Congenita
Metastatic Uveal Melanoma
Iron Deficiency Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Autoimmune Hemolytic Anemia
Cryoglobulinemia
View 11 Less Areas of Focus-

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug
Study Drugs: Fulvestrant, Anastrozole
Study Phase: Phase 3
A Randomized Phase II Trial of Ipilimumab With or Without Bevacizumab in Patients With Unresectable Stage III or Stage IV Melanoma
A Randomized Phase II Trial of Ipilimumab With or Without Bevacizumab in Patients With Unresectable Stage III or Stage IV Melanoma
Enrollment Status: Completed
Publish Date: December 11, 2025
Intervention Type: Biological
Study Drugs: Bevacizumab, Ipilimumab
Study Phase: Phase 2
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Methotrexate, Vinblastine, Doxorubicin, Filgrastim
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Daniel J. Landsburg
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Daniel J. Landsburg
Hematology
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Daniel J. Landsburg
Hematology

Abramson Cancer Center Perelman 4th Floor West

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
 (10.5 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Landsburg is a Hematologist in Philadelphia, Pennsylvania. Dr. Landsburg is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Landsburg is currently accepting new patients.

Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Sunita D. Nasta
Hematology
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Sunita D. Nasta
Hematology

Abramson Cancer Center Perelman 4th Floor West

3400 Civic Center Boulevard, West Pavilion, 4th Floor, 
Philadelphia, PA 
 (10.5 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sunita Nasta is a Hematologist in Philadelphia, Pennsylvania. Dr. Nasta is rated as an Elite provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Nasta is currently accepting new patients.

Jamal G. Misleh
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Jamal G. Misleh
Hematology | Oncology | Internal Medicine
Distinguished in Large-Cell Immunoblastic Lymphoma
Dr. Jamal G. Misleh
Hematology | Oncology | Internal Medicine

Medical Oncology Hematology Consultants

651 North Broad Street, Suite 406, 
Middletown, DE 
 (30.8 miles away)
302-366-1200
Languages Spoken:
English
See accepted insurances

Jamal Misleh is a Hematologist and an Internal Medicine provider in Middletown, Delaware. Dr. Misleh is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Immunoblastic Lymphoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Bone Marrow Aspiration, and Bone Marrow Transplant.

VIEW MORE LARGE-CELL IMMUNOBLASTIC LYMPHOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bach's expertise for a condition
ConditionClose
    • Distinguished
    • Colorectal Cancer
      Dr. Bach is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Bach is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Non-Hodgkin Lymphoma
      Dr. Bach is
      Distinguished
      . Learn about Non-Hodgkin Lymphoma.
      See more Non-Hodgkin Lymphoma experts
    • Advanced
    • Bladder Cancer
      Dr. Bach is
      Advanced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Familial Pancreatic Cancer
      Dr. Bach is
      Advanced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Heyde Syndrome
      Dr. Bach is
      Advanced
      . Learn about Heyde Syndrome.
      See more Heyde Syndrome experts
    • Lynch Syndrome
      Dr. Bach is
      Advanced
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Muscle Invasive Bladder Cancer
      Dr. Bach is
      Advanced
      . Learn about Muscle Invasive Bladder Cancer.
      See more Muscle Invasive Bladder Cancer experts
    • Non-Muscle Invasive Bladder Cancer
      Dr. Bach is
      Advanced
      . Learn about Non-Muscle Invasive Bladder Cancer.
      See more Non-Muscle Invasive Bladder Cancer experts
    View All 10 Advanced Conditions
    • Experienced
    • Adult Immune Thrombocytopenia
      Dr. Bach is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Adult Soft Tissue Sarcoma
      Dr. Bach is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Anemia
      Dr. Bach is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Arterial Embolism
      Dr. Bach is
      Experienced
      . Learn about Arterial Embolism.
      See more Arterial Embolism experts
    • Autoimmune Hemolytic Anemia
      Dr. Bach is
      Experienced
      . Learn about Autoimmune Hemolytic Anemia.
      See more Autoimmune Hemolytic Anemia experts
    • Blood Clots
      Dr. Bach is
      Experienced
      . Learn about Blood Clots.
      See more Blood Clots experts
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.